BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30303078)

  • 1. Free to breathe hard in the Tour de France.
    Valenzuela PL; Santos-Lozano A; Morales JS; Drobnic F; Lucia A
    Lancet; 2018 Sep; 392(10153):1114-1115. PubMed ID: 30303078
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes.
    Pillard F; Lavit M; Cances VL; Rami J; Houin G; Didier A; Rivière D
    Respir Res; 2015 Dec; 16():155. PubMed ID: 26704899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enigma of inhaled salbutamol and sport: unresolved after 45 years.
    Fitch KD
    Drug Test Anal; 2017 Jul; 9(7):977-982. PubMed ID: 28294577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis.
    Haase CB; Backer V; Kalsen A; Rzeppa S; Hemmersbach P; Hostrup M
    Drug Test Anal; 2016 Jul; 8(7):613-20. PubMed ID: 26044066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying beta-agonist utilization: Occasions or puffs?
    Szefler SJ; Hoch HE; Tuffli M; Gondalia R; Barrett MA; Van Sickle D; Stempel DA
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1088-1090. PubMed ID: 30218718
    [No Abstract]   [Full Text] [Related]  

  • 7. Question 2: Blast from the past: is oral salbutamol useful in resource-poor settings?
    O'Reilly DA; Awale A; Cartledge P
    Arch Dis Child; 2015 Aug; 100(8):806-9. PubMed ID: 26187941
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.
    Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
    Clin J Sport Med; 2012 Mar; 22(2):140-5. PubMed ID: 22388343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the urinary threshold concentration of formoterol in sports drug testing.
    Ventura R; Damasceno LM; Ramírez R; Farré M; Bergés R; Segura J
    Drug Test Anal; 2013 Apr; 5(4):266-9. PubMed ID: 23355217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are you taking the medicine?
    Lancet; 1990 Feb; 335(8684):262-3. PubMed ID: 1967723
    [No Abstract]   [Full Text] [Related]  

  • 11. Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol.
    Chrystyn H
    Br J Clin Pharmacol; 1996 Aug; 42(2):257-8. PubMed ID: 8864330
    [No Abstract]   [Full Text] [Related]  

  • 12. Urine concentrations of repetitive doses of inhaled salbutamol.
    Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
    Int J Sports Med; 2011 Aug; 32(8):574-9. PubMed ID: 21563035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative detection of inhaled salmeterol in human urine and relevance to doping control analysis.
    Deventer K; Pozo OJ; Delbeke FT; Van Eenoo P
    Ther Drug Monit; 2011 Oct; 33(5):627-31. PubMed ID: 21912333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teaching corner: Adult asthma in Malawi.
    Coleman M
    Malawi Med J; 2011 Mar; 23(1):22-4. PubMed ID: 23638253
    [No Abstract]   [Full Text] [Related]  

  • 16. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ethnicity, gender, and dehydration on the urinary excretion of inhaled salbutamol with respect to doping control.
    Dickinson J; Hu J; Chester N; Loosemore M; Whyte G
    Clin J Sport Med; 2014 Nov; 24(6):482-9. PubMed ID: 24518370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled salbutamol and doping control: effects of dose on urine concentrations.
    Sporer BC; Sheel AW; Taunton J; Rupert JL; McKenzie DC
    Clin J Sport Med; 2008 May; 18(3):282-5. PubMed ID: 18469572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control.
    Jacobson GA; Hostrup M; Narkowicz CK; Nichols DS; Haydn Walters E
    Drug Test Anal; 2017 Aug; 9(8):1262-1266. PubMed ID: 28033454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What helps for persistent symptoms of asthma during inhalative steroid therapy?].
    Kroegel C
    Dtsch Med Wochenschr; 2011 Oct; 136(42):2130. PubMed ID: 21990055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.